Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that Russ Allison has been appointed Vice President of Sales and Kina Guyton has been appointed Vice President of Medical Products for Heritage’s subsidiary Opticann Inc. (“Opticann”) in the United States.

“Both Kina and Russ bring the decades of experience we need to drive the advancement of Heritage’s U.S. strategy at Opticann, and bring brands to market successfully in the rapid-growth U.S. cannabis and hemp markets,” stated Umar Syed, President, U.S. & International medical products for Heritage. “Their combined experience in sales and product development in the consumer packaged goods industry make them key additions as we build out our U.S. team.”


Mr. Allison has over two decades of experience at Johnson & Johnson Consumer, the Over-The-Counter (OTC) and consumer packaged goods division of this Fortune 50 consumer health company. His roles included Director of Sales, Director of Business Development, and Skin Franchise Trade Marketing. He led multiple new product introductions as well as prescription to over-the-counter product switches. More recently, he has served as the North America general manager for two international corporations to manage their North American business expansion. Mr. Allison has a B.A. in Communications from California State University-Fullarton.

Ms. Guyton has over 20 years of experience at major consumer packaged goods and retail companies including Colgate Palmolive, Coty, and Walgreens as well as a number of emerging consumer product companies. She has crafted the brand strategy for multiple successful novel consumer products. Ms. Guyton joins Opticann with extensive leadership in new product launch, brand management, brand strategy, and building innovative products in new product categories. Ms. Guyton holds an MBA from The Fuqua School of Business at Duke University and a Bachelor of Science Finance degree from The American University, Washington, DC.

About Heritage Cannabis Holdings Corp.

Heritage Cannabis is a vertically integrated cannabis provider that currently has two Health Canada approved licensed producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. both regulated under the Cannabis Act Regulations. Working under these two licenses, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and a Medical Services Division which is focused on cannabis based medical solutions. In the U.S, Heritage operates under Opticann Inc., a Colorado based oral and topical cannabinoid company with the rights to exclusively sell CBD and CBG products made with the patented VESIsorb ® drug delivery system for optimized absorption and stability. As the parent company, Heritage is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS OF Heritage Cannabis HOLDINGS CORP.

“Clint Sharples”
Clint Sharples
CEO

For more information:
Corey Herscu for Heritage Cannabis
corey@verbfactory.com
Tel: 416-300-3030
or
Kelly Castledine
kcastledine@heritagecann.com
Tel: 647-660-2560

News Provided by Business Wire via QuoteMedia

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less